The Safety and Efficacy of Addition of Gentamicin on Irrigation Fluid in Prevention of Post-Transurethral Resection of the Prostate Infectious Complications.
NCT ID: NCT06168708
Last Updated: 2023-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
220 participants
INTERVENTIONAL
2023-12-07
2024-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
the participants will be randomly divided into two groups: Group A (gentamicin group) and group B (Placebo).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT
NCT03589196
Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients
NCT02518971
Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate
NCT01073241
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
NCT02684344
Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)
NCT04212403
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Garamicin group
the participants in this arm will undergo TURP with addition of one ampoule of gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation)
Transurethral resection of the prostate (TURP)
TURP with addition of gentamicin on irrigation fluid to reduce infectious complications
Gentamicin
gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation)
control group
the participants in this arm will undergo TURP with addition of normal saline (2 ml) on the irrigation solution (placebo).
Transurethral resection of the prostate (TURP)
TURP with addition of gentamicin on irrigation fluid to reduce infectious complications
normal saline
normal saline (2 ml) on the irrigation solution (placebo)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transurethral resection of the prostate (TURP)
TURP with addition of gentamicin on irrigation fluid to reduce infectious complications
Gentamicin
gentamicin 80 mg (2ml) /3L of irrigation solution (the first 9 Liters during resection and the first 6 Liters during post-operative irrigation)
normal saline
normal saline (2 ml) on the irrigation solution (placebo)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Renal impairment
* active UTI
* urethral strictures
45 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Zoeir
faculty of medicine, Tanta, ElGeish street, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urolgy Departement, Faculty of Medicine, Tanta University
Tanta, Outside U.S./Canada, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35121/12/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.